zonisamide

Generic: zonisamide

Labeler: bluepoint laboratories
NDC Directory HUMAN PRESCRIPTION DRUG ANDA Inactive Finished

Drug Facts

Product Profile

Brand Name zonisamide
Generic Name zonisamide
Labeler bluepoint laboratories
Dosage Form CAPSULE
Routes
ORAL
Active Ingredients

zonisamide 100 mg/1

Manufacturer
BluePoint Laboratories

Identifiers & Regulatory

Product NDC 68001-244
Product ID 68001-244_4c366d7a-f281-bb5b-e063-6294a90a7b60
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category ANDA
Application Number ANDA077651
Listing Expiration 2027-12-31
Marketing Start 2014-03-13

Pharmacologic Class

Established (EPC)
anti-epileptic agent [epc]
Mechanism of Action
carbonic anhydrase inhibitors [moa] p-glycoprotein inhibitors [moa]
Chemical Structure
sulfonamides [cs]
Physiologic Effect
decreased central nervous system disorganized electrical activity [pe]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 68001244
Hyphenated Format 68001-244

Supplemental Identifiers

RxCUI
314285 403966 403967
UPC
0368001243001 0368001244008
UNII
459384H98V
NUI
N0000175753 N0000008486 M0020790 N0000000235 N0000185503

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name zonisamide (source: ndc)
Generic Name zonisamide (source: ndc)
Application Number ANDA077651 (source: ndc)
Routes
ORAL
source: ndc

Resolved Composition

Strengths
  • 100 mg/1
source: ndc
Packaging
  • 100 CAPSULE in 1 BOTTLE (68001-244-00)
  • 500 CAPSULE in 1 BOTTLE (68001-244-03)
source: ndc

Packages (2)

68001-244-00 100 CAPSULE in 1 BOTTLE (68001-244-00) 68001-244-03 500 CAPSULE in 1 BOTTLE (68001-244-03)

Ingredients (1)

zonisamide (100 mg/1)

Linked Drug Pages (1)

Zonisamide ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["ORAL"], "spl_id": "4c366d7a-f281-bb5b-e063-6294a90a7b60", "openfda": {"nui": ["N0000175753", "N0000008486", "M0020790", "N0000000235", "N0000185503"], "upc": ["0368001243001", "0368001244008"], "unii": ["459384H98V"], "rxcui": ["314285", "403966", "403967"], "spl_set_id": ["345efcc4-6a36-4ddf-8b6c-9c6c844dab0a"], "pharm_class_cs": ["Sulfonamides [CS]"], "pharm_class_pe": ["Decreased Central Nervous System Disorganized Electrical Activity [PE]"], "pharm_class_epc": ["Anti-epileptic Agent [EPC]"], "pharm_class_moa": ["Carbonic Anhydrase Inhibitors [MoA]", "P-Glycoprotein Inhibitors [MoA]"], "manufacturer_name": ["BluePoint Laboratories"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 CAPSULE in 1 BOTTLE (68001-244-00)", "package_ndc": "68001-244-00", "marketing_start_date": "20140313"}, {"sample": false, "description": "500 CAPSULE in 1 BOTTLE (68001-244-03)", "package_ndc": "68001-244-03", "marketing_start_date": "20140313"}], "brand_name": "Zonisamide", "product_id": "68001-244_4c366d7a-f281-bb5b-e063-6294a90a7b60", "dosage_form": "CAPSULE", "pharm_class": ["Anti-epileptic Agent [EPC]", "Carbonic Anhydrase Inhibitors [MoA]", "Decreased Central Nervous System Disorganized Electrical Activity [PE]", "P-Glycoprotein Inhibitors [MoA]", "Sulfonamides [CS]"], "product_ndc": "68001-244", "generic_name": "Zonisamide", "labeler_name": "BluePoint Laboratories", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Zonisamide", "active_ingredients": [{"name": "ZONISAMIDE", "strength": "100 mg/1"}], "application_number": "ANDA077651", "marketing_category": "ANDA", "marketing_start_date": "20140313", "listing_expiration_date": "20271231"}